SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $219.00 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Investments › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2022-11-03
- 2022-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $219.00M.
- 2022-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $211.85M.
- 2022-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $212.55M.
- 2021-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $197.68M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2022-09-30 | $219.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $211.85M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $212.55M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $197.68M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $246.46M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $359.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $464.11M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $510.09M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $389.43M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $197.41M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $272.38M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $282.05M 10-Q · filed 2020-11-04 |
| 2019-09-30 | $240.56M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $271.88M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $259.71M 10-Q · filed 2019-11-06 |